跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BRINZOLAMIDA/BRIMONIDINA STADA 10 MG/ML + 2 MG/ML COLIRIO EN SUSPENSION - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
BRINZOLAMIDA/BRIMONIDINA STADA 10 MG/ML + 2 MG/ML COLIRIO EN SUSPENSION
Approved
STANDARD
BRINZOLAMIDA/BRIMONIDINA STADA 10 MG/ML + 2 MG/ML COLIRIO EN SUSPENSION
Laboratorio Stada S.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Feb 27, 2024
Approval ID
126dd3a5c7f0b132
Company
Laboratorio Stada S.L.
Type
Standard
Approval Details
Approval Id
126dd3a5c7f0b132
Drug Cima Aemps Name
BRINZOLAMIDA/BRIMONIDINA STADA 10 MG/ML + 2 MG/ML COLIRIO EN SUSPENSION
Register Number
89398
Holder Company Name
Laboratorio Stada S.L.
Marketing Company Name
Laboratorio Stada S.L.
Authorization Date
2024-02-27
Dosage Form
COLIRIO EN SUSPENSIÓN
Dose
10 mg/ml + 2 mg/ml
Route Of Administration
VÍA OFTÁLMICA
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Laboratorio Stada S.L.
Active Ingredients
BRINZOLAMIDA
10 mg/ml
BRIMONIDINA TARTRATO
2 mg/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Feb 27, 2024
Approval ID
126dd3a5c7f0b132
Type
Standard
Back to CIMA-AEMPS Approvals